EMEA-002839-PIP01-20-M01
Submitted by Anonymous (not verified) on 13 March 2024 - 13:04
EMEA-002839-PIP01-20-M01
EMEA-002700-PIP01-19-M01
Submitted by Anonymous (not verified) on 13 March 2024 - 12:56
EMEA-002700-PIP01-19-M01
Blenrep : EPAR - Public assessment report
Submitted by Anonymous (not verified) on 13 March 2024 - 11:28
Blenrep : EPAR - Public assessment report
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 22 January 2024, 10:00 (CET) to 22 January 2024, 13:30 (CET)
Submitted by Anonymous (not verified) on 13 March 2024 - 11:16
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 22 January 2024, 10:00 (CET) to 22 January 2024, 13:30 (CET)
Innovation Task Force (ITF) briefing meeting request form
Submitted by Anonymous (not verified) on 13 March 2024 - 9:25
Innovation Task Force (ITF) briefing meeting request form
Paediatric Committee (PDCO): 16-19 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 January 2024 to 19 January 2024
Submitted by Anonymous (not verified) on 13 March 2024 - 9:18
Paediatric Committee (PDCO): 16-19 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 January 2024 to 19 January 2024
Orphan designation: (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol bedaquiline Treatment of tuberculosis, 26/08/2005 Withdrawn
Submitted by Anonymous (not verified) on 13 March 2024 - 8:03
Orphan designation: (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol bedaquiline Treatment of tuberculosis, 26/08/2005 Withdrawn
Multi-stakeholder workshop on Data Quality Framework for Adverse Drug Reaction reporting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 March 2024, 09:30 (CET) to 1 March 2024, 15:40 (CET)
Submitted by Anonymous (not verified) on 12 March 2024 - 16:25
Multi-stakeholder workshop on Data Quality Framework for Adverse Drug Reaction reporting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 March 2024, 09:30 (CET) to 1 March 2024, 15:40 (CET)
CTIS Bitesize Talk: How to submit a transitional trial in CTIS, Online, Broadcast, from 29 February 2024, 16:30 (CET) to 29 February 2024, 18:00 (CET)
Submitted by Anonymous (not verified) on 12 March 2024 - 15:22
CTIS Bitesize Talk: How to submit a transitional trial in CTIS, Online, Broadcast, from 29 February 2024, 16:30 (CET) to 29 February 2024, 18:00 (CET)
Coordination of pharmacovigilance inspections
Submitted by Anonymous (not verified) on 12 March 2024 - 14:00
Coordination of pharmacovigilance inspections